● Recruiting

Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome

Condition: Intracranial Artery Stenosis · Sponsor: Nanjing First Hospital, Nanjing Medical University

PhaseNA

Planned participants180

Who can joinAll sexes, 18 Years to 85 Years

Healthy volunteersNo

About this study

sICASBLM is a prospective controlled trial, to asses the impact of improving blood lipid management on clinical outcome of moderate to severe symptomatic intracranial atherosclerotic stenosis patients (LDL-C\>1.8mmol/L) without endovascular therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Junshan Zhou · 8602587726218 · zhjsh333@126.com

Qiwen Deng · 8602587726218 · qiw_deng@163.com

Always discuss trial participation with your own doctor first.

Locations (2)

Nanjing First Hospital, Nanjing Medical University	Nanjing, Jiangsu, China	Recruiting
Nanjing First Hospital	Nanjing, Jiangsu, China	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05397405